Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.580974
Abstract: Novel adjuvants, such as Toll-like receptors (TLRs) agonists, are needed for the development of new formulations able to circumvent limitations of current vaccines. Among TLRs, TLR7/8 agonists represent promising candidates, as they are well described…
read more here.
Keywords:
liposome formulation;
doepc based;
type ifn;
agonist including ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1102524
Abstract: A vaccine adjuvant known as Adjuvant System 01 (AS01) consists of liposomes containing a mixture of natural congeners of monophosphoryl lipid A (MPL®) obtained from bacterial lipopolysaccharide, and a tree saponin known as QS21. Two…
read more here.
Keywords:
formulation qs21;
army liposome;
liposome formulation;
adjuvant system ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23147999
Abstract: This work focuses on formulating liposomes to be used in isolated kidney dynamic machine perfusion in hypothermic conditions as drug delivery systems to improve preservation of transplantable organs. The need mainly arises from use of…
read more here.
Keywords:
liposome formulation;
kidney;
perfusion;
vitro testing ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911662
Abstract: Targeted delivery of drugs or other therapeutic agents through internal or external triggers has been used to control and accelerate the release from liposomal carriers in a number of studies, but relatively few utilize energy…
read more here.
Keywords:
liposome formulation;
release;
radiation;
tumor ... See more keywords